إعلان
إعلان

NVS

NVS logo

Novartis AG

137.86
USD
برعاية
-0.86
-0.62%
٣١ ديسمبر, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

137.84

-0.02
-0.02%

تقارير أرباح NVS

النسبة الإيجابية المفاجئة

NVS تفوق 24 من 39 آخر التقديرات.

62%

التقرير التالي

بيانات التقرير القادم
٠٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$14.11B
/
$1.98
التغير الضمني من Q3 25 (Revenue/ EPS)
+1.41%
/
-12.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+7.24%
/
--

Novartis AG earnings per share and revenue

On ٢٨ أكتوبر ٢٠٢٥, NVS reported earnings of 2.25 USD per share (EPS) for Q3 25, missing the estimate of 2.29 USD, resulting in a -2.11% surprise. Revenue reached 13.91 مليار, compared to an expected 14.31 مليار, with a -2.81% difference. The market reacted with a -4.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 1.98 USD, with revenue projected to reach 14.11 مليار USD, implying an decrease of -12.00% EPS, and increase of 1.41% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Novartis AG reported EPS of $2.25, missing estimates by -2.11%, and revenue of $13.91B, -2.81% below expectations.
The stock price moved down -4.42%, changed from $129.14 before the earnings release to $123.43 the day after.
The next earning report is scheduled for ٠٤ فبراير ٢٠٢٦.
Based on 8 analysts, Novartis AG is expected to report EPS of $1.98 and revenue of $14.11B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان